Saturday, 1st October 11:00 SESSION II
/ Chairs: F. Aucella; L. Gottin

SEPSIS AND MODS

P46

Effects of the Timing and Intensity of treatment on Septic Shock patients treated with CytoSorb®: Clinical ExperienceBerlot G, Samola V, Barbaresco I, Tomasini A, Di Maso V, Bianco F and Gerini UTrieste

P47

Renal and Hepatic support in Severe Septic Shock from Leptospirosis: a “Case Series” and the adoption of a New Dialysis ProtocolLentini P, Benedetti C, Laudadio G, Andrighetto S, Fuso V, Vienna F, Berlingò G, Previti ABassano del Grappa

P48

CytoSorb® hemoadsorption improves haemodynamics and SOFA Score in Septic ShockAucella F, Pellegrino AM, Ferrara G, Gatta G, Vaira P, Del Gaudio ASan Giovanni Rotondo

P50

Preliminary results of antibiotics pharmacokinetics in critically ill children with septic shock treated with CKRT and Cytosorb hemoperfusionBottari G, Maccarrone C, Cappoli A, Marano M, Cairoli S, Ventura V, Mazzeo AT, Goffredo B, Guzzo I, Cecchetti CRoma

P52
P53

Hemodynamic Assessment with CytoSorb® treatment in Lemierre’s SyndromeBarile A, Recchia A, Mirabella L, Cinnella G, Del Gaudio AFoggia

P54

CytoSorb® on the Septic ShockGrabocka X, Di Stante S, Bertuzzi V, Martello M, Belcastro S, Kulurianu H, Pizzolante F, Cardillo A, Paci Della Costanza O, Silvestri C, Di Luca MPesaro, Fano

P56

Use of CytoSorb® in Childhood Onset Systemic Lupus Erythematosus (c-SLE) Septic ShockMilella L, Ficarella MT, Calabrese G, Sisto M, Lenoci F, Cito F, Moliterni P, Lasorella MLBari

P58

Pancreatic Stone Protein (PSP) as a Predictive biomarker of Multiple Organ Failure and Clinical OutcomeLosappio V, Sangregorio F, Maiorano A, Infante B, Stasi A, Netti GS, Spadaccino F, Ranieri E, Stallone G, Castellano GFoggia, Milano

P60

Pancreatic Stone Protein (PSP) as a Sepsis Biomarker in patients admitted to Intensive CareZani G, Felloni G, Di Antonio F, Graziani E, Valbonetti M, Fiducioso D, Menchise F, Dal Checco E, Gecele C, Valenti S, Fusari MRavenna